A Phase 2, Open‐label, Randomized, Multiple‐dose Study Evaluating Inarigivir in Treatment‐naïve Patients with Chronic Hepatitis B
Liver International（2022）
Key words
HBsAg level,HBV DNA suppression,Inarigivir,retinoic acid-inducible gene 1,tenofovir
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined